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Abstract 
Canine respiratory coronavirus (CRCoV), identified in 2003, is a member of the Coronaviridae family. The virus is a 
betacoronavirus and a close relative of human coronavirus OC43 and bovine coronavirus. Here, we examined entry of 
CRCoV into human rectal tumor cells (HRT-18G cell line) by analyzing co-localization of single virus particles with cel-
lular markers in the presence or absence of chemical inhibitors of pathways potentially involved in virus entry. We also 
targeted these pathways using siRNA. The results show that the virus hijacks caveolin-dependent endocytosis to enter 
cells via endocytic internalization.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Coronaviruses are enveloped, single-stranded, positive-
sense RNA viruses belonging to the family Coronaviridae 
within the order Nidovirales [1]. Based on its properties, 
this family can be divided into four distinct genus: alpha, 
beta, delta, and gamma. Coronaviruses infect a wide vari-
ety of birds and mammals, including humans, livestock, 
and companion animals [1–3]. Human coronaviruses 
(HCoVs) are associated mainly with relatively mild upper 
and lower respiratory tract disease; however, emergence 
of severe acute respiratory syndrome coronavirus (SARS-
CoV) in the winter of 2002–2003 in China, and more 
recently Middle East respiratory syndrome coronavi-
rus (MERS-CoV) in the Middle East, demonstrates the 
potential threat posed by zoonotic coronaviruses [2–4].
Canine respiratory coronavirus (CRCoV) was first 
identified in 2003 in samples obtained from the respira-
tory tracts of dogs with canine infectious respiratory 
disease (CIRD; also known as kennel cough) that were 
housed in animal shelters in the United Kingdom [5]. 
CIRD is a contagious disease with high morbidity but 
low mortality; it usually occurs in densely housed dog 
populations (e.g., rehoming centers, veterinary hospitals). 
Characterized by a dry, hacking cough, the disease is gen-
erally mild and self-limiting. However, it can progress to 
a potentially fatal bronchopneumonia [6, 7]. CIRD is con-
sidered a complex infection, with a multifactorial etiology 
in which a number of organisms (including Bordetella 
bronchiseptica, canine parainfluenza virus, canine adeno-
virus type 1 and 2, canine herpesvirus, Mycoplasma spp., 
canine pneumovirus, and influenza viruses) are involved 
[6, 8]. It is believed that CRCoV plays a role in the early 
stages of CIRD by limiting ciliary clearance of the upper 
airways. Consequently, infection leads to reduced respir-
atory clearance and sensitization to secondary infections 
[5–7].
CRCoV is closely related to two other betacorona-
viruses, bovine coronavirus (BCoV) and HCoV-OC43 
(97.3% nucleotide identity in the spike gene for BCoV 
and 96.9% for OC43 as reported by Erles et al. [5]), but 
is clearly distinct from Canine Enteric Coronavirus 
(CECoV, previously known as Canine Coronavirus) [5, 
7]. CRCoV is a difficult pathogen to work with because 
the only confirmed susceptible cell line is a human rec-
tal tumor cell line (HRT-18) and its derivative HRT-18G. 
No canine cell line supports replication of the virus. 
Open Access
*Correspondence:  k.a.pyrc@uj.edu.pl 
2 Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian 
University, Krakow, Poland
Full list of author information is available at the end of the article
Page 2 of 14Szczepanski et al. Vet Res  (2018) 49:55 
Furthermore, CRCoV does not produce a cytopathic 
effect in HRT-18 cells [8].
To initiate infection, enveloped viruses fuse with host 
cell membrane prior to delivering genetic material. This 
process may occur at the cell surface (e.g., human immu-
nodeficiency virus, herpes simplex virus); otherwise 
prior internalization is required [2, 9]. To enter the cell, 
viruses hijack a number of different endocytic pathways, 
including macropinocytosis and clathrin-mediated, cave-
olin-mediated, and clathrin- and caveolin-independent 
routes [2, 9, 10]. For example, SARS-CoV uses clathrin-
dependent, lipid raft-mediated, and clathrin- and caveo-
lae-independent entry pathways [2, 11–13]. In addition, 
feline infectious peritonitis virus (FIPV) uses clathrin- 
and caveolin-independent endocytic routes [14], whereas 
HCoV-229E uses caveolae-dependent endocytosis [15]. 
Furthermore, some human respiratory coronaviruses 
may utilize protease activation to modulate the route of 
entry [16–18]. Generally, within each of these endocytic 
pathways, vesicles are formed through interaction of cer-
tain protein networks. Early vesicles provide a starting 
point for trafficking, which leads to endosome matura-
tion and allows sorting of incoming cargo [19, 20]. Some 
internalized vesicles are recycled back to the cell surface, 
while others are converted, for example to lysosomes. 
Sorting of cargo is regulated by Rab GTPases, which 
serve as molecular hallmarks of different routes [19–21].
Here, we studied internalization of CRCoV into HRT-
18G cells. The results clearly demonstrated that CRCoV 
entry into HRT-18G cells requires endocytic internaliza-
tion prior to membrane fusion, a process that requires 
caveolin-1 and dynamin. Furthermore, fusion of the viral 
and cellular membranes occurs before the endosome 
progresses to the late phase.
Materials and methods
Cells and viruses
HRT-18G (ATCC CRL-11663) cells, derivative of HRT-18 
(ATCC  CCL-244, ileocecal colorectal adenocarcinoma) 
were maintained in Dulbecco’s MEM (Life Technologies, 
Poland) supplemented with 3% heat-inactivated fetal 
bovine serum (Life Technologies), penicillin (100 U/mL), 
streptomycin (100 μg/mL), and ciprofloxacin (5 μg/mL). 
Cells were cultured at 37 °C under 5%  CO2. Virus stock of 
canine respiratory coronavirus strain 4182 was prepared 
by infecting HRT-18G cells monolayers and collecting 
supernatant 5  days post-infection (pi). Obtained stock 
was aliquoted and stored at −80  °C. The control from 
mock-infected cells was prepared in the same manner. 
Virus yield was estimated by titration on confluent HRT-
18G cells according to the method of Reed and Muench 
[22]. As CPE is not visible, cells were infected at 37 °C for 
5 days, fixed and immunostained to detect virus-infected 
cells. For co-localization studies, stocks were concen-
trated using Amicon Ultra Centrifugal Filters (Merck, 
10-kDa cutoff), aliquoted, and stored at −80 °C.
Chemical inhibitors
DMEM supplemented with 100 U/mL penicillin, 100 μg/
mL streptomycin and one of the following chemi-
cal inhibitors: 1-aminoadamantane (100  µM, AMTD, 
Sigma-Aldrich, Poland), Pitstop (10 µM, Abcam), chlor-
promazine (1.5 µM, Sigma-Aldrich), filipin III (2 μg/mL, 
Sigma-Aldrich), nystatin (50  µg/mL, Sigma-Aldrich), 
methyl-β-cyclodextrin (5  mM, MβCD, Sigma-Aldrich), 
5-(N-ethyl-N-isopropyl)amiloride (10  µM, EIPA, Sigma-
Aldrich), 1,1′-Dithiobis-2-naphthalenol (20  µM, IPA-
3, Sigma-Aldrich), wortmannin (5  µM, Calbiochem), 
dynasore (80 µM, Abcam), iminodyn 22 (25 µM, Abcam), 
mitmab (5  µM, Abcam), ammonium chloride (50  mM, 
 NH4Cl, Bioshop), bafilomycin A1 (10  nM, Sigma-
Aldrich), cytochalasin D (10  µM, Sigma-Aldrich), jas-
plakinolide (1.5  µM, Calbiochem), nocodazole (0.5  μM, 
Sigma-Aldrich), cell permeable Rho inhibitor (1  µg/mL, 
CT04 Cytoskeleton Inc.), N6-[2-[[4-(Diethylamino)-
1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-me-
thyl-4,6-quinolinediamine trihydrochloride (100  μM 
NSC23766), (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyri-
dyl)cyclohexanecarboxamide dihydrochloride (10  μM, 
Y27632 Sigma-Aldrich), Decanoyl-Arg-Val-Lys-Arg-
chloromethyl ketone (5–100 μM, Santa Cruz Biotechnol-
ogy) were used to pretreat HRT-18G cells for 1 h at 37 °C.
Inhibition of viral replication
Cells pretreated with chemical inhibitors for 1 h at 37 °C 
(full list at Additional file 1), were exposed to virus at a 
50% tissue culture infectious dose  (TCID50) of 400 in the 
presence of inhibitors. Two hours pi cells were washed 
with PBS twice to remove unbound virus, and medium 
with fresh inhibitors was added to each well. Five days pi 
cells were harvested for further analysis. Cell viability was 
tested at day five pi using XTT based Cell Proliferation 
Kit (Biological Industries), according to the manufactur-
er’s instructions.
FACS analysis
Cells treated with inhibitors were harvested at 5  day pi 
by trypsinization, centrifuged (5  min, 300 ×  g), washed 
with PBS, fixed in 4% formalin in PBS (15  min, room 
temperature (RT)) and permeabilized (0.5% Triton X-100 
in PBS, 20  min, RT, Bioshop). Unspecific binding sites 
were blocked (5% bovine serum albumin (BSA, Bioshop) 
in PBS, 2 h RT) prior to staining. Further, cells were incu-
bated with anti-coronavirus antibody OC43 strain (1 µg/
mL, Merck) for 2 h and with secondary Alexa Fluor 488 
goat anti-mouse antibody (5  µg/mL, Thermo Scientific, 
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Poland) for 1 h. Cells were washed with 0.5% Tween-20, 
resuspended in PBS, and analyzed with flow cytometry 
(FACSCalibur, Becton Dickinson).
Confocal microscopy
Cells cultured on coverslips in 6-well plate for 48 h were 
washed with ice-cold PBS and incubated with concen-
trated CRCoV at 4 °C for 60 min and subsequently incu-
bated at 37  °C for 0–180  min. Coverslips were washed 
thrice with PBS, fixed in 4% formalin for 15 min, permea-
bilized with 0.5% Tween-20 (Bioshop) for 20 min (unless 
stated otherwise). Unspecific binding sites were blocked 
using 5% BSA in PBS (4 °C, overnight) prior to staining. 
For visualization of CRCoV particles anti-coronavirus 
antibody OC43 strain (1 µg/mL, 2 h, RT, Merck) coupled 
with goat anti-mouse Alexa Fluor 488 antibody (5  µg/
mL, 1  h, RT, Thermo Scientific) was used. To visualize 
host cell proteins, cells were blocked using 10%  FBS in 
PBS (4  °C, overnight) and incubated (2 h, RT) with one 
of the following antibodies: caveolin-1 antibody (2  µg/
mL, Santa Cruz Biotechnology), clathrin HC antibody 
(2  µg/mL, Santa Cruz Biotechnology), EEA1 antibody 
(2  µg/mL, Santa Cruz Biotechnology), Rab  7 antibody 
(2  µg/mL, Santa Cruz Biotechnology), endophilin B2 
antibody (2  µg/mL, Santa Cruz Biotechnology), Rab  11 
antibody (2.67  µg/mL, Proteintech), LAMP antibody 
(10  µg/mL, Thermo Scientific) coupled with second-
ary goat anti-rabbit Alexa Fluor 546 (10 µg/mL, Thermo 
Scientific). Signal specificity was verified using isotype 
control (normal rabbit IgG, normal goat IgG, Santa Cruz 
Biotechnology). Following this, cells were washed thrice 
with 0.5% Tween-20 in PBS. Nuclear DNA was stained 
with 4′,6′-diamidino-2-phenylindole (DAPI, 0.1  μg/mL, 
Sigma-Aldrich). Stained coverslips were mounted on 
glass slides in Prolong Diamond medium (Thermo Scien-
tific). Fluorescent images were acquired using Zeiss LSM 
710 confocal microscope (Carl Zeiss Microscopy GmbH).
Inhibitors influence on initial phase of infection
Cells pretreated with chemical inhibitors were incubated 
with concentrated CRCoV in the presence of inhibitors at 
37 °C for 2 h. Two hours pi cells were washed with PBS 
twice to remove unbound virus, fixed with 4% formalin 
in PBS (15 min, RT) and permeabilized with 0.5% Tween-
20. Unspecific binding sites were blocked using 5% BSA 
in PBS (4  °C, overnight) prior to staining. CRCoV was 
visualized using anti-coronavirus antibody OC43 strain 
(1 µg/mL, 2 h, RT, Merck) coupled with goat anti-mouse 
Alexa Fluor 488 antibody (5  µg/mL, 1  h, RT, Thermo 
Scientific). For this study Alexa-Fluor 647 Phalloidin 
(4  U/mL, 1  h, RT, Thermo Scientific) labeled actin cor-
tex was assumed to indicate cell surface. Nuclear DNA 
was stained with DAPI (0.1  μg/mL, Sigma-Aldrich) and 
coverslips were mounted on glass slides in Prolong Dia-
mond medium.
Post‑entry inhibitory effects
Cells were infected with CRCoV at  TCID50 of 400/mL. 
After 2 h incubation unbound virus was washed off with 
PBS and cells were overlaid with culture medium con-
taining chemical inhibitors. Five days pi cells were har-
vested for further analysis.
Role of furin during the infection
Cells were infected with CRCoV at  TCID50 of 400/mL. 
After 2 h incubation at 37 °C unbound virus was washed 
off with PBS and cells were overlaid with culture medium 
containing decanoyl-RVKR-chloromethyl ketone (dec-
RVKR-CMK). Four days pi cells were fixed, stained and 
fluorescent images were acquired.
siRNA transfection
HRT-18G cells were transfected with 25 pmol of caveo-
lin-1 siRNA (sc-29241, Santa Cruz Biotechnology) or 
scrambled negative control siRNA (sc-44237, Santa Cruz 
Biotechnology) using lipofectamine RNAiMAX reagent 
(Thermo Scientific) according to manufacturer’s pro-
tocol. Two consecutive transfections were performed 
24 h and 48 h after cell seeding. Subsequently, cells were 
infected and prepared for imaging.
Computer analysis
All graphs presented in this work were created using 
GraphPad Prism 6 software. Significance was estimated 
using one-way ANOVA with multiple comparisons to 
virus control. Images obtained from the confocal micro-
scope were deconvolved using AutoQuant X3 and pro-
cessed in ImageJ Fiji [23]. Co-localization analyses were 
performed in ImageJ using JACoP plugin [24] where 
Pearson’s and Manders’ coefficient were calculated for 
3D cell reconstructions. The bioinformatics analysis was 
conducted using arginine and lysine propeptide cleav-
age sites prediction algorithms ProP 1.0 server [25] using 
the following sequence data: AAO06124.1 (isolate 4182), 
ABG78748.1 (isolate 4182), ACX46840.1 (strain K9), 
AFW97360.1 (strain K37), ACX46860.1 (strain K39) and 
AQT26498.1 (strain BJ232).
Results
CRCoV enters HRT‑18G cells via endocytosis
Weak bases such as  NH4Cl were previously described 
to hamper endosomal  entry of viruses, by preventing 
pH-dependent activation of the fusion protein, subse-
quently blocking membrane fusion [26]. Treatment of 
HRT-18G cells with 50 mM  NH4Cl inhibited replication 
of CRCoV (5.9 ± 9.9% of control, Additional file  2), but 
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did not inhibit virus entry into host cells (Figures 1A and 
B). Bafilomycin A1 inhibits vacuolar  H+-ATPases and 
blocks endosome acidification [27]. Similarly, bafilomy-
cin  A1 blocked virus replication (93.5%  ±  5.2% reduc-
tion in number of infected cells, compared to control) 
(Additional file  2), but not virus entry (Figures  1A  and 
B). Surprisingly, addition of bafilomycin  A1 or  NH4Cl 
2 h pi also resulted in decreased virus replication. Similar 
observations were made for the most of tested inhibitors 
of intracellular trafficking (Additional file 2). For this rea-
son we decided to use for the analysis only the data on 
virus entry.
Consequently, to test whether the virus enters the cell 
by endocytosis, we examined co-localization of viral par-
ticles with early endosome antigen 1 (EEA1) at different 
times post-infection (pi). Co-localization was clearly vis-
ible (Figure 2), peaking at 60–90 min pi (Mander’s coef-
ficient 0.63 ± 0.18 at 60 min and 0.64 ± 0.12 at 90 min pi). 
No co-localization with the late endosome marker Rab 7, 
the lysosome marker LAMP1, or the endosome marker 
Rab 11 was visible at any time (Additional files 3, 4).
Obtained results suggest that CRCoV undergoes fusion 
already in an early endosomal compartment, what may 
seem contradictory to some previous reports [2, 28–30]. 
However, some viruses are processed by furin in the 
producer cell, what makes the processing by cathepsins 
dispensable [31]. As in silico analysis predicted poten-
tial furin cleavage site in CRCoV spike glycoprotein gene 
(Additional file 5), effect of dec-RVKR-CMK (5–100 µM, 
Santa Cruz Biotechnology) on virus replication as well as 
cell-to-cell spread was tested. As visible on Figure  3 no 
alteration of virus entry was observed.
Inhibition of CRCoV entry into HRT‑18G cells
Next, we used inhibitors of endocytosis to examine the 
endocytic pathway utilized by CRCoV to enter HRT-18G 
cell. All inhibitors were used at the highest non-toxic 
concentration (determined in an XTT assay; data not 
shown). The validity of the obtained data was verified 
using positive controls (transferrin, cholera toxin subunit 
B  (CHTxB), and dextran), which enter the cell via clath-
rin-dependent pathway, caveolin-dependent pathway, 
and macropinocytosis, respectively [9, 32].
To determine whether CRCoV enters HRT-18G cells 
by clathrin-mediated endocytosis (CME), we treated cells 
with chlorpromazine, amantadine, or PitStop-2 [33, 34]. 
None of the compounds affected the virus entry to the 
cells (Figures 4A and B).
Caveolae, rich in cholesterol and sphingolipids, are 
disrupted by sterol-binding agents, as nystatin, filipin, 
or MβCD. Filipin had no effect on virus entry; neither 
did it hamper internalization of  CHTxB, implying inef-
fectiveness of this inhibitor on HRT-18G cell line. Nys-
tatin and MβCD blocked virus internalization to the cell 
(Figures  5A  and B), suggesting that caveolae are essen-
tial during CRCoV internalization. To ensure that the 
observed effect is not an artifact, caveolin-1 expression 
was silenced using siRNAs. As shown in Figure 6, deple-
tion of caveolin-1 resulted in reduction in number of 
virus particles entering the cell. 
Figure 1 Effect of endosome alkalization on CRCoV infection. A Analysis of inhibitors effect on CRCoV entry, cells were pretreated with 
inhibitors, infected in presence of them and incubated for 1 h before they were washed off and fixed. CRCoV virions are presented in green, blue 
denotes DNA and red represents actin, each image is a single confocal plane while B represents maximum projections of their axial planes. Scale 
bar 10 µm.
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Figure 2 Co‑localization of CRCoV with early endosome marker EEA1. Virus treated cells were synchronized on ice for 60 min and incubated 
at 37  °C before they were washed and fixed with 4% paraformaldehyde in PBS. Localization was analyzed by confocal microscopy after performing 
a double immunofluorescence staining to visualize virus nucleocapsid (left) and early endosomes (middle). Right panel shows merged image with 
virus presented as green and EEA1 as red. Cell nuclei are shown in blue. Control—negative control, cells incubated with mock sample (green) and 
stained with isotype antibodies (red). Scale bar 10 µm. Graph presents co-localization change in time.
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To check whether the virus enters cells via macropi-
nocytosis, we treated them with the  NA+/H+ exchanger 
inhibitor EIPA, the Pak-1 inhibitor IPA-3, and the PI3K 
inhibitor wortmannin [35]. No effect on virus entry was, 
however, observed (Figures 7A and B).
Co‑localization of virus particles with markers of endocytic 
pathways
The above results showed that only compounds that 
interfere with caveosome formation affect CRCoV entry. 
However, some reports show that these compounds have 
off-target and multi-target activity [36–39]. Therefore, 
to ensure the validity of the obtained data, we examined 
co-localization of virus particles with markers of differ-
ent endocytic pathways. Cells were exposed to virus for 
0–180  min. As shown in Figure  8, CRCoV co-localized 
with caveolin at 20 min pi, and this was maintained for 
up to 120 min pi. Visual assessment and analysis of co-
localization coefficients revealed that co-localization was 
more marked than for  CHTxB, which utilizes the caveo-
lin-1 mediated pathway to enter cells (Figures  5C  and 
8D). We also examined whether the virus co-localizes 
with clathrin (Figure 9) or endophilin (Additional file 6). 
No co-localization was detected. 
Dynamin is important for CRCoV internalization
Dynamin is essential for several endocytic pathways [14, 
40, 41]. Therefore, we asked whether this GTPase plays 
Figure 3 Effect of furin inhibitor—decanoyl‑RVKR‑chloromethyl ketone (CMK) on CRCoV replication (A) and cell to cell spread (B). A 
Graph shows number of virus positive cells at  4th day pi normalized to control. HRT-18G cells were pretreated with inhibitor before infection and it 
was present post-infection. B 3 h pi cells were overlaid with CMK containing medium and were propagated in this conditions until fixation at  4th 
day pi. CRCoV virions are presented in green, blue denotes DNA and red represents actin. Scale bar 20 µM.
Figure 4 Effect of clathrin‑mediated endocytosis inhibitors on 
CRCoV infection. A Analysis of inhibitors effect on CRCoV entry, 
cells were pretreated with inhibitors, infected in presence of them 
and incubated for 1 h before they were washed off and fixed. CRCoV 
virions are presented in green, blue denotes DNA and red represents 
actin, each image is a single confocal plane while B represents 
maximum projections of their axial planes. Scale bar 10 µm.
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a role in CRCoV entry into cells. For this, we used three 
inhibitors of dynamin, which inhibited GTPase activity 
(dynasore and iminodyn-22) [42, 43] or blocked the lipid 
binding (MiTMAB) [44]. All three inhibitors affected 
virus replication: dynasore by 87.8 ± 7.5%, iminodyn-22 
by 60.0 ± 1.5%, and MiTMAB by 94.1 ± 3.7% (Additional 
file  2) when added before infection. What is even more 
important, their effect was limited when added only post-
infection (Additional file  2), suggesting that dynamin 
is important at early stages of infection. All inhibitors 
caused a marked reduction in the number of virions 
entering the cell (Figures 10A and B). Recently, Xu et al. 
[45] studied JEV entry into the cells and proposed a new 
model—actin- and dynamin-dependent caveolae-medi-
ated endocytosis. Thus, we analyzed the effect of inhib-
iting Rho, Rac1, and ROCK kinases on virus infection. 
Only inhibition of Rac1 (by NSC23766) hampered viral 
replication showing significantly stronger effect when 
Figure 5 Effect of caveolin‑mediated endocytosis inhibitors on CRCoV. A Analysis of inhibitors effect on CRCoV infection, cells were pretreated 
with inhibitors, infected in presence of them and incubated for 1 h before they were washed off and fixed. CRCoV virions are presented in green, 
blue denotes DNA and red represents actin, each image is a single confocal plane while B represents maximum projections of their axial planes. C 
Comparison of CRCoV and CHTxB co-localization with caveolin-1. Scale bar 10 µm.
Figure 6 siRNA treatment. HRT-18G cells were transfected twice using scrambled negative control siRNA or caveolin-1 siRNA, infected, 
synchronized on ice for 60 min and incubated at 37  °C for 60 min before they were washed and fixed. CRCoV virions are presented in green, blue 
denotes DNA and red represents caveolin 1 (A) or actin (B), each image is a single confocal plane. C Negative control for staining. Bar 10 µm D 
Western blot signal of caveolin-1 and GAPDH expression in transfected cells. ctrl: control, sh: sham transfected cells, scRNA: scrambled RNA, siRNA: 
caveolin-1 siRNA. Scale bar 10 µm.
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present prior to infection (7.9% ± 9.3 of control) than 
after (51.9% ± 3.6 of control) (Additional file 2) implying 
its involvement in entry process.
Cytoskeleton
The results so far suggest that CRCoV enters HRT-18G 
cells via caveolin- and dynamin-dependent endocytosis, 
and that it is likely that fusion occurs early after internali-
zation. Therefore, we examined the role of the cytoskel-
eton during virus entry. First, we evaluated the effect 
of an actin-disrupting agent (cytochalasin D), an actin 
stabilizing compound (jasplakinolide), and an inducer 
of microtubule depolimerization (nocodazole) [46, 47]. 
Additional file 2 shows that, while microtubules are not 
important for virus infection, actin plays a central role 
during the early stages of CRCoV infection. Disrupting 
actin filaments led to a reduction (by 84.5% ± 8.9) in viral 
infection, although filament stabilization had no effect on 
virus yield. Lack of this effect after post-entry treatment 
(Additional file  2) imply that actin is required during 
early events of CRCoV infection. Studies of virus locali-
zation revealed that after treatment with cytochalasin D, 
multiple viral particles localize to actin aggregates (Fig-
ures 11A and B); this implies that an intact actin cytoskel-
eton plays a role in intracellular transport of viruses.
Discussion
To propagate, viruses need to deliver their genetic mate-
rial into the host cell. To do this, enveloped viruses fuse 
with the cellular membrane prior to ejecting genomic 
RNA or DNA into the cytoplasm. This may take place on 
the cell surface or after endocytosis. Here, we identified 
the pathway by which CRCoV enters human epithelial 
cells (HRT-18G) [8].
First, we asked whether CRCoV enters cells via endocy-
tosis. Sensitivity to lysosomotropic agents is considered 
good evidence of endocytosis [48]; therefore, we treated 
cells with inhibitors of endosome acidification (bafilo-
mycin A and ammonium chloride). Both compounds 
hampered virus infection, suggesting that CRCoV enters 
HRT-18G cells via endocytosis rather than via direct 
membrane fusion. However, inhibitory effect of inhibi-
tors altering the endosomal pH was observed also on the 
replication stage. Similar phenomenon was previously 
reported for SARS-CoV [49]. It was suggested that these 
compounds interfere with glycosylation of the viral pro-
teins and in such a way suppress their expression and 
assembly [49, 50]. Nonetheless, we decided to present the 
data on virus replication in supplementary material and 
focus on virus entry to the cell.
No single pathway of entry has been reported for 
Coronaviridae. Indeed, studies have identified clathrin-
dependent, caveolin-dependent, clathrin-and-caveolin-
independent, and endocytosis-independent routes (see 
Table 1). To identify the route of entry used by CRCoV, 
we utilized inhibitors of several different pathways (see 
Additional file  1). However, it is worth remembering 
that chemical inhibitors may affect other phases of virus 
replication by interfering with viral and cellular proteins 
(e.g., kinases, GTPases) [32, 51]. Indeed, we observed 
such non-specific interaction and consequently it was 
not possible to test the effect of chemical inhibitors on 
virus replication, as virus yields were reduced by almost 
all compounds affecting intracellular trafficking. To fur-
ther address this issue, we employed complementary 
approaches: siRNA-mediated knockdown of caveolin-1 
and analysis of co-localization of CRCoV viral particles 
with markers of different intracellular compartments. 
Figure 7 Effect of macropinocytosis inhibitors on CRCoV 
infection. A Analysis of inhibitors effect on CRCoV entry, cells 
were pretreated with inhibitors, infected in presence of them and 
incubated for 1 h before they were washed off and fixed. CRCoV 
virions are presented in green, blue denotes DNA and red represents 
actin, each image is a single confocal plane while B represents 
maximum projections of their axial planes. Scale bar 10 µm.
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The results revealed that CRCoV enters the cell via the 
caveolin-1 dependent pathway; indeed, CRCoV particles 
co-localized with endosomes coated with caveolin-1, 
but not with clathrin or endophilin (Additional file  6). 
Furthermore, siRNA-mediated depletion of caveolin-1 
inhibited virus entry.
Next, we focused on dynamin, an important GTPase 
involved in vesicle scission during endocytosis. While 
it is most commonly associated with clathrin-mediated 
endocytosis, it also plays a role in phagocytosis and 
caveolin-1, ILR-2-, and flotillin-dependent endocytosis 
[14, 40, 41]. To do this, we used three dynamin inhibi-
tors, two that inhibit GTPase activity and one that blocks 
the lipid-binding domain of dynamin. The results led 
us to conclude that CRCoV entry into HRT-18G cells is 
dynamin-dependent.
In order to monitor intracellular trafficking of CRCoV 
and to determine the specific point of virus-cell mem-
brane fusion, we examined co-localization of the 
CRCoV nucleocapsid protein and endosomal vesicle 
markers. The results showed that CRCoV was present 
in early endosomes but absent from late and recycling 
endosomes and lysosomes. This indicates that fusion of 
CRCoV and cellular membranes occurs at an early stage, 
before the endosome recruit Rab 7 and progresses to the 
late phase. This is different from the majority of corona-
viruses, which travel far along the endocytic pathway to 
access high cathepsin activity (e.g., SARS-CoV, MHV, 
FIPV, porcine epidemic diarrhea coronavirus) [2, 28, 30]. 
The pathway used by CRCoV is more similar to that used 
by MERS-CoV reported to utilize furin as well as trans-
membrane protease serine 2 (TMPRSS2) [2, 17, 28, 29, 
31]. We tested the influence of furin inhibitor decanoyl-
RVKR-chloromethyl ketone in order to study the impor-
tance of furin for CRCoV entry. No inhibition of virus 
replication or cell to cell spread was noted, showing that 
furin processing is not relevant for CRCoV entry. One 
may however speculate that regardless of fusion with 
the host membrane occurring early after internaliza-
tion, CRCoV may still utilize cathepsins similarly to most 
Figure 8 CRCoV co‑localize with caveolin. Cells treated with virus were synchronized on ice for 60 min and incubated at 37 °C for 20, 40, 60, or 
120  min before they were washed and fixed. Caveolin-1 are presented on A (red channel) while B shows stained virus nucleocapsid protein (green 
channel). C Depicts merged image with marked co-localization. D FITC conjugated CHTxB (green) co-localizing with caveolin-1 (red) after 40 (upper) 
and 60 (lower) min. E Negative controls for staining. Scale bar 10 µm.
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coronaviruses. Even if cathepsins is considered to require 
acidic pH for activation this dependency varies according 
to substrate and so far a few substrates were described 
to be cleaved in slightly acidic pH comparable to that 
achieved before endosome maturation [52–54]. Another 
potential explanation is cleavage by other proteases such 
as cell surface TMPRSS2 recently reported to be pre-
ferred over cathepsins by several coronaviruses [18, 29].
Our last objective was to study the role of the cytoskel-
eton during CRCoV infection. We discovered that in cells 
treated with cytochalasin D prior to infection, virus rep-
lication was reduced and during entry the virions accu-
mulated on actin aggregates. Surprisingly, another actin 
inhibitor, jasplakinolide, had no significant effect on virus 
replication or entry. Interestingly, cytochalasin D and 
jasplakinolide affect the actin cytoskeleton via oppos-
ing mechanisms: cytochalasin D inhibits polymeriza-
tion of actin subunits, whereas jasplakinolide stabilizes 
filaments by inhibiting depolymerization [46, 55]. The 
results obtained using these two agents suggest that actin 
filaments, but not actin reorganization, are required for 
CRCoV entry.
Coronaviruses are a family of viruses with high 
zoonotic potential. As such, they present a real threat to 
the global economy and to public health [4, 56–58]. Here, 
we show that CRCoV relies on dynamin-dependent, 
Figure 9 CRCoV (A) does not co‑localize with clathrin in opposite to Alexa Fluor 488 conjugated transferrin (B). Cells treated with virus 
or transferrin were synchronized on ice for 60 min and incubated at 37 °C for 2, 5 or 20 min before they were washed and fixed. Clathrin HC are 
presented in red while stained virus nucleocapsid protein in green. C Negative controls for staining. D Co-localization changes in time. Scale bar 
10 µm.
Figure 10 Vesicle scission—dynamin dependence. A Analysis of 
inhibitors effect on CRCoV entry, cells were pretreated with inhibitors, 
infected in presence of them and incubated for 1 h before they 
were washed off and fixed. CRCoV virions are presented in green, 
blue denotes DNA and red represents actin, each image is a single 
confocal plane while B represents maximum projections of their axial 
planes. Scale bar 10 µm.
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Figure 11 Effect of cytoskeleton reorganization on CRCoV entry. A Analysis of inhibitors effect on CRCoV entry, cells were pretreated with inhibitors, 
infected in presence of them and incubated for 1 h before they were washed off and fixed. CRCoV virions are presented in green, blue denotes DNA and 
red represents actin, each image is a single confocal plane while B presents maximum projection of their axial planes. Scale bar 10 µm.
Table 1 Entry pathways described for Coronaviruses
Virus Genus Entry route Cells References
HCoV-229E Alpha pH dependent endocytosis Caco-2 (human colon adenocarcinoma), 
MRC-5 (human lungs)
[59]
Caveolin-dependent endocytosis, lipid raft 
mediated
Human primary fibroblasts, L132 (human 
embryonic lung cell line)
[15]
Endocytosis—laboratory strains, membrane 
fusion—clinical isolates
HeLa-229 (human cervix), HAE (human 
airway epithelium)
[18]
Membrane fusion HEK 293T (human embryonic kidney), 
Caco-2 (human colon adenocarcinoma)
[16]
HCoV-NL63 Alpha Clathrin-dependent endocytosis LLC-MK2 (rhesus monkey kidney) HAE 
(human airway epithelium)
[60]
Feline infectious peritonitis Alpha Clathrin- and caveolin-independent endocytosis Primary feline monocytes [14]
Transmissible gastroenteritis virus Alpha Lipid raft mediated ST (swine testicles) [61]
Canine enteric Coronavirus Alpha Lipid raft mediated A72 (canine fibroma) [62]
Mouse hepatitis virus Beta Cell membrane fusion Mouse 3T3-L2 fibroblast [63]
pH dependent endocytosis Murine fibroblast [64]
Lipid raft mediated DBT cells (mouse astrocytoma) [65]
SARS-CoV Beta Clathrin-dependent endocytosis HepG2 (human hepatoma) [13]
Membrane fusion Vero E6 (African green monkey kidney) [66]
Lipid raft mediated Vero E6 (African green monkey kidney) [11]
Clathrin- and caveolin-independent endocy-
tosis
HEK 293E (human embryonic kidney) , Vero 
E6 (African green monkey kidney)
[12]
Membrane fusion Vero E6 (African green monkey kidney), HEK 
293T (human embryonic kidney)
[67]
MERS-CoV Beta Virus-cell fusion HEK 293T (human embryonic kidney), 
Caco-2 (human colon adenocarcinoma)
[17]
HCoV-OC43 Beta Caveolin-dependent endocytosis HCT-8 (human adenocarcinoma) [68]
Avian infectious bronchitis virus Gamma Low-pH-dependent virus-cell fusion BHK (hamster kidney) [69]
Lipid raft mediated Vero (African green monkey kidney) [70]
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caveolin-1-mediated endocytosis to enter host cells. 
Moreover, we showed that fusion with the host mem-
brane occurs early after internalization.
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